Immunogen – Lost In Translation

It finally happened. Yesterday, Genentech announced that they made a...
by Ohad Hammer - Oct 15, 2008 - in Stock Picks

When There Is Blood In The Streets - Buy Biotech

History has shown again and again that times like these represent a huge long term...
by Ohad Hammer - Oct 10, 2008 - in Economy

Another Seal of Approval For Micromet

There is always a debate regarding market efficiency and to what extent stock...
by Ohad Hammer - Aug 18, 2008 - in Economy

Genentech’s New Shiny Platform

On June 18th, Seattle Genetics (SGEN) announced it had received a milestone...
by Ohad Hammer - Aug 04, 2008 - in Economy

Immunogen at ASCO 2008

Many terms can be used to describe Immunogen’s (IMGN) recent stock behavior, but...
by Ohad Hammer - Jul 14, 2008 - in Economy

Immunogen and Seattle Genetics – On The Verge Of An Inflection Point

This year's ASCO annual meeting should be a very exciting event for anyone...
by Ohad Hammer - May 23, 2008 - in Economy

Go to Article Archives